165 related articles for article (PubMed ID: 24095161)
1. Generation, characterization and therapeutic potential of anti-feline TNF-alpha MAbs for feline infectious peritonitis.
Doki T; Takano T; Nishiyama Y; Nakamura M; Hohdatsu T
Res Vet Sci; 2013 Dec; 95(3):1248-54. PubMed ID: 24095161
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis.
Doki T; Takano T; Kawagoe K; Kito A; Hohdatsu T
Res Vet Sci; 2016 Feb; 104():17-23. PubMed ID: 26850532
[TBL] [Abstract][Full Text] [Related]
3. Development of monoclonal antibodies (MAbs) to feline interferon (fIFN)-γ as tools to evaluate cellular immune responses to feline infectious peritonitis virus (FIPV).
Satoh R; Kaku A; Satomura M; Kohori M; Noura K; Furukawa T; Kotake M; Takano T; Hohdatsu T
J Feline Med Surg; 2011 Jun; 13(6):427-35. PubMed ID: 21334239
[TBL] [Abstract][Full Text] [Related]
4. Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP.
Hohdatsu T; Yamato H; Ohkawa T; Kaneko M; Motokawa K; Kusuhara H; Kaneshima T; Arai S; Koyama H
Vet Microbiol; 2003 Dec; 97(1-2):31-44. PubMed ID: 14637036
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the pathogenesis of granulomatous lesions.
Takano T; Azuma N; Satoh M; Toda A; Hashida Y; Satoh R; Hohdatsu T
Arch Virol; 2009; 154(5):775-81. PubMed ID: 19343474
[TBL] [Abstract][Full Text] [Related]
6. Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes.
Hohdatsu T; Yamada H; Ishizuka Y; Koyama H
Microbiol Immunol; 1993; 37(6):499-504. PubMed ID: 7694052
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages.
Takano T; Hohdatsu T; Toda A; Tanabe M; Koyama H
Virology; 2007 Jul; 364(1):64-72. PubMed ID: 17382365
[TBL] [Abstract][Full Text] [Related]
8. Characterization of antiviral T cell responses during primary and secondary challenge of laboratory cats with feline infectious peritonitis virus (FIPV).
Mustaffa-Kamal F; Liu H; Pedersen NC; Sparger EE
BMC Vet Res; 2019 May; 15(1):165. PubMed ID: 31118053
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of oral type I feline infectious peritonitis virus (FIPV) infection: Antibody-dependent enhancement infection of cats with type I FIPV via the oral route.
Takano T; Yamada S; Doki T; Hohdatsu T
J Vet Med Sci; 2019 Jun; 81(6):911-915. PubMed ID: 31019150
[TBL] [Abstract][Full Text] [Related]
10. Some aspects of humoral and cellular immunity in naturally occuring feline infectious peritonitis.
Paltrinieri S; Cammarata MP; Cammarata G; Comazzi S
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):205-20. PubMed ID: 9839875
[TBL] [Abstract][Full Text] [Related]
11. Detection of antigenic heterogeneity in feline coronavirus nucleocapsid in feline pyogranulomatous meningoencephalitis.
Poncelet L; Coppens A; Peeters D; Bianchi E; Grant CK; Kadhim H
Vet Pathol; 2008 Mar; 45(2):140-53. PubMed ID: 18424826
[TBL] [Abstract][Full Text] [Related]
12. B-cell activation in cats with feline infectious peritonitis (FIP) by FIP-virus-induced B-cell differentiation/survival factors.
Takano T; Azuma N; Hashida Y; Satoh R; Hohdatsu T
Arch Virol; 2009; 154(1):27-35. PubMed ID: 19043660
[TBL] [Abstract][Full Text] [Related]
13. The influence of age and genetics on natural resistance to experimentally induced feline infectious peritonitis.
Pedersen NC; Liu H; Gandolfi B; Lyons LA
Vet Immunol Immunopathol; 2014 Nov; 162(1-2):33-40. PubMed ID: 25265870
[TBL] [Abstract][Full Text] [Related]
14. Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.
Takano T; Katoh Y; Doki T; Hohdatsu T
Antiviral Res; 2013 Aug; 99(2):100-7. PubMed ID: 23648708
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus.
Hohdatsu T; Yamada M; Tominaga R; Makino K; Kida K; Koyama H
J Vet Med Sci; 1998 Jan; 60(1):49-55. PubMed ID: 9492360
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of types I and II feline coronavirus infections in cats.
Hohdatsu T; Okada S; Ishizuka Y; Yamada H; Koyama H
J Vet Med Sci; 1992 Jun; 54(3):557-62. PubMed ID: 1322718
[TBL] [Abstract][Full Text] [Related]
17. A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.
Hohdatsu T; Nakamura M; Ishizuka Y; Yamada H; Koyama H
Arch Virol; 1991; 120(3-4):207-17. PubMed ID: 1659798
[TBL] [Abstract][Full Text] [Related]
18. Natural feline coronavirus infection: differences in cytokine patterns in association with the outcome of infection.
Kipar A; Meli ML; Failing K; Euler T; Gomes-Keller MA; Schwartz D; Lutz H; Reinacher M
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):141-55. PubMed ID: 16621029
[TBL] [Abstract][Full Text] [Related]
19. Shifts in circulating lymphocyte subsets in cats with feline infectious peritonitis (FIP): pathogenic role and diagnostic relevance.
Paltrinieri S; Ponti W; Comazzi S; Giordano A; Poli G
Vet Immunol Immunopathol; 2003 Dec; 96(3-4):141-8. PubMed ID: 14592727
[TBL] [Abstract][Full Text] [Related]
20. Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection.
Doki T; Takano T; Koyama Y; Hohdatsu T
Virus Res; 2015 Jun; 204():13-20. PubMed ID: 25896976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
